| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.52 | 0.07 |